Physician profile
Tarun Chakravarty
NPI 1194097303
$67,191.45
in general payments reported to CMS, 2019-2025
19 companies · $16K in 2025
The $16K reported for 2025 was more than what 92% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9,497 · 2020: $4,274 · 2021: $3,677 · 2022: $5,450 · 2023: $5,130 · 2024: $23K · 2025: $16K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $27K · Consulting Fee: $6,985 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $6,500 · Travel and Lodging: $3,680 · Grant: $95.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $27,033.08 |
| Consulting Fee | $6,985.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $6,500.00 |
| Travel and Lodging | $3,680.00 |
| Grant | $95.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $32,565.57 | 2019-2025 | Sapien 3 Ultra Resilia, Pascal, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Boston Scientific Corporation | $26,666.38 | 2019-2025 | Watchman Access System, Watchman Flx, Clinical Trial Product |
| Abbott Laboratories | $3,485.40 | 2019-2025 | Amplatzer, Pressurewire, Dragonfly Opstar |
| Abiomed | $945.51 | 2024-2025 | Impella |
| Shockwave Medical, INC | $813.15 | 2024-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Biosense Webster, INC. | $600.31 | 2024 | Thermocool Sf |
| W. L. Gore & Associates, INC. | $330.99 | 2019-2025 | Gore Cardioform Septal Occluder |
| Philips North America LLC | $309.58 | 2019-2025 | Ice 3d, Intracardiac Undivided |
| Heartflow, INC. | $308.03 | 2023-2025 | Ffrct |
| Medtronic, INC. | $280.93 | 2022-2025 | Symplicity G3, Corevalve Evolut R |
| Boehringer Ingelheim Pharmaceuticals, INC. | $244.56 | 2023-2024 | Jardiance |
| Penumbra, INC. | $234.53 | 2022 | |
| Amgen INC. | $145.40 | 2023 | Repatha |
| Atricure, INC. | $129.19 | 2022 | |
| Janssen Pharmaceuticals, INC | $40.11 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Recor Medical INC | $33.87 | 2025 | Paradise Ultrasound Renal Denervation System |
| Kiniksa Pharmaceuticals International, Plc | $32.90 | 2024 | Arcalyst |
| Itamar Medical INC | $13.75 | 2024 | Watchpatone |
| Medtronic Vascular, INC. | $11.29 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tarun Chakravarty listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.